Clinical Trials Logo

Acute Liver Injury, Drug Induced clinical trials

View clinical trials related to Acute Liver Injury, Drug Induced.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06285253 Not yet recruiting - Acute Liver Failure Clinical Trials

miroliverELAP® for the Treatment of Acute Liver Failure: A Phase 1 Trial

Start date: May 1, 2024
Phase: Phase 1
Study type: Interventional

The clinical trail will assess the safety of miroliverELAP for the treatment of acute liver failure without underlying chronic liver disease. miroliverELAP is an external liver assist combination product consisting of a single-use MIRO-001 bioengineered liver graft and an extracorporeal blood circuit. miroliverELAP Is intended to support the native (failed) liver for up to 48-hours of continuous treatment to allow time for liver recovery or to identify a transplantable liver.